Noha A. Nagui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noha A. Nagui has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Rania Abdel Hay
Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
4 shared publications - Doaa Mahgoub
Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt
3 shared publications - Galal El Enany
The Dermatology Department, Cairo University, Kasr Al Aini Hospital, Cairo, Egypt
2 shared publications - Heba M. Mashaly
Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
2 shared publications Laila Ahmed Rashed
Medical Biochemistry and Molecular Biology Department Faculty of Medicine Cairo University Cairo Egypt
2 shared publications- Rana Fathy Hilal
Department of Dermatology, Kasr Al Ainy Teaching Hospital Cairo University Cairo Egypt
2 shared publications
Latest Publications
- 5 May 2020
- Published by Wiley in International Journal of Dermatology
- Vol. 59 (8) , E274-E276
Stage IV adrenal neuroblastoma with subcutaneous nodules in an infant: a case report
- 5 May 2020
- Published by Wiley in International Journal of Dermatology
- Vol. 59 (8) , E274-E276
Stage IV adrenal neuroblastoma with subcutaneous nodules in an infant: a case report
- 27 October 2018
- Published by Wiley in International Journal of Dermatology
- Vol. 58 (5) , 589-592
Cutaneous expression of thymic stromal lymphopoietin (TSLP) in vitiligo patients: a case‐control study
Background: Thymic stromal lymphopoietin (TSLP) is a major pro‐allergic cytokine promoting T helper‐2 responses. Our aim was to study and verify the hypothesis of the role of TSLP in the pathogenesis of vitiligo.Methods: This case‐control study was conducted on 25 patients with generalized non‐segmental vitiligo (recruited from the Dermatology outpatient clinic, Kasr El Ainy, Faculty of Medicine, Cairo University) and 25 healthy controls fulfilling the inclusion criteria over a period of 7 months (January 2017–July 2017). Patients underwent complete medical history, detailed assessment of vitiligo, and photographic documentation. Skin biopsies were taken from the back from both patients’ vitiliginous skin and from normal skin of controls for which relative TSLP messenger RNA (mRNA) tissue expression levels were measured using quantitative real‐time polymerase chain reaction technique.Results: There was a statistically significant difference between the TSLP mRNA expression levels in patients and controls (P < 0.001) with lower levels in the former group.Conclusion: This study revealed lower TSLP mRNA expression levels in vitiliginous skin than in normal skin suggesting an imminent role of TSLP in the pathogenesis of vitiligo.
- 27 October 2018
- Published by Wiley in International Journal of Dermatology
- Vol. 58 (5) , 589-592
Cutaneous expression of thymic stromal lymphopoietin (TSLP) in vitiligo patients: a case‐control study
Background: Thymic stromal lymphopoietin (TSLP) is a major pro‐allergic cytokine promoting T helper‐2 responses. Our aim was to study and verify the hypothesis of the role of TSLP in the pathogenesis of vitiligo.Methods: This case‐control study was conducted on 25 patients with generalized non‐segmental vitiligo (recruited from the Dermatology outpatient clinic, Kasr El Ainy, Faculty of Medicine, Cairo University) and 25 healthy controls fulfilling the inclusion criteria over a period of 7 months (January 2017–July 2017). Patients underwent complete medical history, detailed assessment of vitiligo, and photographic documentation. Skin biopsies were taken from the back from both patients’ vitiliginous skin and from normal skin of controls for which relative TSLP messenger RNA (mRNA) tissue expression levels were measured using quantitative real‐time polymerase chain reaction technique.Results: There was a statistically significant difference between the TSLP mRNA expression levels in patients and controls (P < 0.001) with lower levels in the former group.Conclusion: This study revealed lower TSLP mRNA expression levels in vitiliginous skin than in normal skin suggesting an imminent role of TSLP in the pathogenesis of vitiligo.
- 1 May 2018
- Published by Medknow in Journal of the Egyptian Womenʼs Dermatologic Society
- Vol. 15 (2) , 113-115
Hidradenocarcinomas mimicking mycetoma
Malignant eccrine tumors are a group of extremely rare and aggressive dermatoses. In this case report, we present a 65-year-old woman who developed a unilateral multinodular swelling on the ankle of 4 months duration. The biopsy result was a histological surprise and revealed characters consistent with hidradenocarcinoma which is a rare rapidly metastasizing tumor of eccrine glands.
- 1 May 2018
- Published by Medknow in Journal of the Egyptian Womenʼs Dermatologic Society
- Vol. 15 (2) , 113-115
Hidradenocarcinomas mimicking mycetoma
Malignant eccrine tumors are a group of extremely rare and aggressive dermatoses. In this case report, we present a 65-year-old woman who developed a unilateral multinodular swelling on the ankle of 4 months duration. The biopsy result was a histological surprise and revealed characters consistent with hidradenocarcinoma which is a rare rapidly metastasizing tumor of eccrine glands.
- 1 January 2018
- Published by Medknow in Journal of the Egyptian Womenʼs Dermatologic Society
- Vol. 15 (1) , 10-14
Expression of soluble and membrane-bound programmed death protein 1 in psoriasis vulgaris patients
- 1 January 2018
- Published by Medknow in Journal of the Egyptian Womenʼs Dermatologic Society
- Vol. 15 (1) , 10-14
Expression of soluble and membrane-bound programmed death protein 1 in psoriasis vulgaris patients
- 6 October 2015
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 58 (2) , e36-e39
Assessment of gene expression levels of proopiomelanocortin (POMC) and melanocortin‐1 receptor (MC1R) in vitiligo
Proopiomelanocortin (POMC) and melanocortin 1 receptor (MC1R) are regulators of melanogenesis and pigmentation. Our objective was to estimate their levels, searching for a possible role of the melanocortin system in vitiligo. This study included 40 vitiligo patients and 40 controls. Skin biopsies were taken from lesional and non‐lesional skin of patients and from the non‐sun exposed skin of controls to detect the expression of POMC and MC1R using quantitative real‐time polymerase chain reaction. Both factors were significantly lower in lesional than non‐lesional skin and controls, while they were significantly higher in non‐lesional skin than in controls. There was a statistically significant positive correlation between lesional levels of POMC and MC1R, as well as between non‐lesional levels of POMC and MC1R in the patients. On the other hand, we found a statistically significant negative correlation between the lesional and non‐lesional levels of POMC, as well as between the lesional and non‐lesional levels of MC1R in the patients. As a conclusion, the melanocortin system could play a role in the pathogenesis of vitiligo or could be affected as the end result of the disease.
- 6 October 2015
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 58 (2) , e36-e39
Assessment of gene expression levels of proopiomelanocortin (POMC) and melanocortin‐1 receptor (MC1R) in vitiligo
Proopiomelanocortin (POMC) and melanocortin 1 receptor (MC1R) are regulators of melanogenesis and pigmentation. Our objective was to estimate their levels, searching for a possible role of the melanocortin system in vitiligo. This study included 40 vitiligo patients and 40 controls. Skin biopsies were taken from lesional and non‐lesional skin of patients and from the non‐sun exposed skin of controls to detect the expression of POMC and MC1R using quantitative real‐time polymerase chain reaction. Both factors were significantly lower in lesional than non‐lesional skin and controls, while they were significantly higher in non‐lesional skin than in controls. There was a statistically significant positive correlation between lesional levels of POMC and MC1R, as well as between non‐lesional levels of POMC and MC1R in the patients. On the other hand, we found a statistically significant negative correlation between the lesional and non‐lesional levels of POMC, as well as between the lesional and non‐lesional levels of MC1R in the patients. As a conclusion, the melanocortin system could play a role in the pathogenesis of vitiligo or could be affected as the end result of the disease.
- 25 May 2015
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 41 (2) , 124-128
Possible role of proenkephalin in psoriasis
Our results support the role of PENK in the aetiopathogenesis of psoriasis, and indicate that giving anti-PENK drugs in addition to current antipsoriatic therapies might be of value in treating this common chronic skin disease.
- 25 May 2015
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 41 (2) , 124-128
Possible role of proenkephalin in psoriasis
Our results support the role of PENK in the aetiopathogenesis of psoriasis, and indicate that giving anti-PENK drugs in addition to current antipsoriatic therapies might be of value in treating this common chronic skin disease.
- 1 November 2011
- Published by JLE in European Journal Of Dermatology
- Vol. 21 (6) , 866-869
Effect of narrow band ultraviolet B on survivin in psoriatic skin lesions
Suppression of apoptosis is responsible for epidermal thickness in psoriasis. Survivin is an anti-apoptotic protein that can be modulated by ultraviolet B (UVB). Our aim was to investigate the role of survivin in psoriasis and to evaluate the effect of narrow band (NB)-UVB on the survivin levels in psoriatic lesions. This study included 20 psoriatic patients and 20 healthy controls. Patients were treated with 24 sessions of NB-UVB. Skin biopsies were taken from the affected skin of each patient before and after treatment, and from the controls, to examine survivin levels by ELISA. Survivin was significantly upregulated in psoriasis compared to controls (p<0.001). We found significant positive correlations between survivin levels before therapy and the extent of body involvement (r=0.675, p=0.002), as well as the PASI score (r=0.67, p=0.001). A significant decrease in survivin levels was observed post treatment compared to baseline levels (p<0.001). We found increased survivin levels in psoriasis and a significant reduction following NB-UVB induced clinical improvement of psoriasis.
- 1 November 2011
- Published by JLE in European Journal Of Dermatology
- Vol. 21 (6) , 866-869
Effect of narrow band ultraviolet B on survivin in psoriatic skin lesions
Suppression of apoptosis is responsible for epidermal thickness in psoriasis. Survivin is an anti-apoptotic protein that can be modulated by ultraviolet B (UVB). Our aim was to investigate the role of survivin in psoriasis and to evaluate the effect of narrow band (NB)-UVB on the survivin levels in psoriatic lesions. This study included 20 psoriatic patients and 20 healthy controls. Patients were treated with 24 sessions of NB-UVB. Skin biopsies were taken from the affected skin of each patient before and after treatment, and from the controls, to examine survivin levels by ELISA. Survivin was significantly upregulated in psoriasis compared to controls (p<0.001). We found significant positive correlations between survivin levels before therapy and the extent of body involvement (r=0.675, p=0.002), as well as the PASI score (r=0.67, p=0.001). A significant decrease in survivin levels was observed post treatment compared to baseline levels (p<0.001). We found increased survivin levels in psoriasis and a significant reduction following NB-UVB induced clinical improvement of psoriasis.
- 24 December 2010
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 36 (3) , 302-304
Estimation of (IgA) anti-gliadin, anti-endomysium and tissue transglutaminase in the serum of patients with psoriasis
Studies have indicated an association between psoriasis and coeliac disease (CD), an immune-mediated gluten-dependent enteropathy; however, the precise relationship between psoriasis and CD remains controversial. We aimed to assess the prevalence of the CD-associated IgA antibodies antigliadin antibody (AGA), tissue transglutaminase (tTG) and antiendomysium antibody (EMA) in patients with psoriasis. In total, 41 patients with psoriasis and 41 healthy controls were enrolled in this study. Blood samples were taken from all participants, and screened for AGA, tTG and EMA. We found a significantly higher level of AGA in patients with psoriasis than in controls, but levels of tTG and EMA were not significant. There was also a significantly higher prevalence of AGA, tTG and EMA in the patient group (34.1%, 34.1% and 14.6%, respectively) than in the control group (2.4%, 22% and 4.9%, respectively). We conclude that the significantly high prevalence of AGA antibodies in patients with psoriasis supports the possibility of a link between psoriasis and gluten-sensitive enteropathies, especially CD.
- 24 December 2010
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 36 (3) , 302-304
Estimation of (IgA) anti-gliadin, anti-endomysium and tissue transglutaminase in the serum of patients with psoriasis
Studies have indicated an association between psoriasis and coeliac disease (CD), an immune-mediated gluten-dependent enteropathy; however, the precise relationship between psoriasis and CD remains controversial. We aimed to assess the prevalence of the CD-associated IgA antibodies antigliadin antibody (AGA), tissue transglutaminase (tTG) and antiendomysium antibody (EMA) in patients with psoriasis. In total, 41 patients with psoriasis and 41 healthy controls were enrolled in this study. Blood samples were taken from all participants, and screened for AGA, tTG and EMA. We found a significantly higher level of AGA in patients with psoriasis than in controls, but levels of tTG and EMA were not significant. There was also a significantly higher prevalence of AGA, tTG and EMA in the patient group (34.1%, 34.1% and 14.6%, respectively) than in the control group (2.4%, 22% and 4.9%, respectively). We conclude that the significantly high prevalence of AGA antibodies in patients with psoriasis supports the possibility of a link between psoriasis and gluten-sensitive enteropathies, especially CD.
- 10 September 2010
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 35 (7) , 781-785
Expression of cyclin D1 and p16 in psoriasis before and after phototherapy
Psoriasis vulgaris (PV) is characterized by keratinocyte hyperproliferation. Altered expression of cell-cycle regulatory genes involved in the cyclin D1 ⁄ p16 INK4-pRb pathway may contribute to this epidermal hyperproliferation. To assess the expression of cyclin D1 and p16 in psoriasis, and to evaluate the effect of phototherapy on their expression. The study population comprised 25 patients with PV and 10 healthy controls. Patients were treated with 24 sessions of either narrowband ultraviolet (UV) B or psoralen UVA. Skin biopsies were taken from the affected skin of each patient before and after treatment, and from the healthy controls, to examine cyclin D1 and p16 expression. Before phototherapy, the mean value of cyclin D1 concentration in patients was significantly greater than that in controls and the mean value of p16 concentration in patients was significantly lower than that in controls. Following treatment, we detected a significant decrease in cyclin D1 and a significant increase in p16. Cyclin D1 upregulation and p16 downregulation may play a role in the pathogenesis of psoriasis. Normalization of the levels of both parameters may be a mechanism by which phototherapy induces remission in psoriasis.
- 10 September 2010
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 35 (7) , 781-785
Expression of cyclin D1 and p16 in psoriasis before and after phototherapy
Psoriasis vulgaris (PV) is characterized by keratinocyte hyperproliferation. Altered expression of cell-cycle regulatory genes involved in the cyclin D1 ⁄ p16 INK4-pRb pathway may contribute to this epidermal hyperproliferation. To assess the expression of cyclin D1 and p16 in psoriasis, and to evaluate the effect of phototherapy on their expression. The study population comprised 25 patients with PV and 10 healthy controls. Patients were treated with 24 sessions of either narrowband ultraviolet (UV) B or psoralen UVA. Skin biopsies were taken from the affected skin of each patient before and after treatment, and from the healthy controls, to examine cyclin D1 and p16 expression. Before phototherapy, the mean value of cyclin D1 concentration in patients was significantly greater than that in controls and the mean value of p16 concentration in patients was significantly lower than that in controls. Following treatment, we detected a significant decrease in cyclin D1 and a significant increase in p16. Cyclin D1 upregulation and p16 downregulation may play a role in the pathogenesis of psoriasis. Normalization of the levels of both parameters may be a mechanism by which phototherapy induces remission in psoriasis.
- 28 July 2010
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 23 (4) , 428-434
A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides
Psoriasis, vitiligo, and mycosis fungoides (MF) are among the most frequently treated dermatological diseases by photo(chemo)therapy. The objectives are to determine which photo (chemo) therapeutic modality could achieve the best response in the treatment of psoriasis, vitiligo, and MF. The design used in this study is retrospective analytical study. The study included 745 patients' records; 293 with psoriasis, 309 with vitiligo, and 143 with early MF, treated in the Phototherapy Unit, Dermatology Department, Kasr El‐Aini Hospital, Cairo University by either psoralen and ultraviolet A (PUVA), narrow band ultraviolet B (NB‐UVB), psoralen and narrow band UVB (P‐NBUVB), broad band UVB (BB‐UVB), or broad band UVA (ΒΒ‐UVA). Data were retrieved from the computer database of the unit and statistically analyzed. In psoriasis, oral and topical PUVA and NB‐UVB were found to be equally effective, whereas oral PUVA had significantly better results than both UVA and BB‐UVB at the end of therapy. In generalized vitiligo, PUVA and P‐NBUVB had significantly better results than NB‐UVB alone. In early MF, there was no statistically significant difference between the response to oral PUVA and NB‐UVB. PUVA and NB‐UVB are good choices in patients with psoriasis and early stage MF, whereas PUVA appears the best choice in the treatment of vitiligo.
- 28 July 2010
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 23 (4) , 428-434
A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides
Psoriasis, vitiligo, and mycosis fungoides (MF) are among the most frequently treated dermatological diseases by photo(chemo)therapy. The objectives are to determine which photo (chemo) therapeutic modality could achieve the best response in the treatment of psoriasis, vitiligo, and MF. The design used in this study is retrospective analytical study. The study included 745 patients' records; 293 with psoriasis, 309 with vitiligo, and 143 with early MF, treated in the Phototherapy Unit, Dermatology Department, Kasr El‐Aini Hospital, Cairo University by either psoralen and ultraviolet A (PUVA), narrow band ultraviolet B (NB‐UVB), psoralen and narrow band UVB (P‐NBUVB), broad band UVB (BB‐UVB), or broad band UVA (ΒΒ‐UVA). Data were retrieved from the computer database of the unit and statistically analyzed. In psoriasis, oral and topical PUVA and NB‐UVB were found to be equally effective, whereas oral PUVA had significantly better results than both UVA and BB‐UVB at the end of therapy. In generalized vitiligo, PUVA and P‐NBUVB had significantly better results than NB‐UVB alone. In early MF, there was no statistically significant difference between the response to oral PUVA and NB‐UVB. PUVA and NB‐UVB are good choices in patients with psoriasis and early stage MF, whereas PUVA appears the best choice in the treatment of vitiligo.